Code Bio is a company developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases. It uses a synthetic DNA delivery platform, 3DNA®, designed to manage the delivery of genetic medicines, such as dose-related toxicity, off-target effects, immunogenicity, gene size and delivery limitations, bioavailability, ability to re-dose, and vector manufacturing complexity.